Dollberg S, Warner B W, Myatt L
Department of Pediatrics, Children's Hospital Medical Center, University of Cincinnati, College of Medicine, Ohio 45267-0526.
Pediatr Res. 1995 Jan;37(1):31-4.
Persistent pulmonary hypertension of the newborn (PPHN) often requires extracorporeal membrane oxygenation (ECMO), during which time pulmonary vascular resistance gradually declines. Nitric oxide (NO) is a recently recognized pulmonary vasodilator, but its role in PPHN is unknown. We tested the hypothesis that the concentrations of the urinary metabolites of NO, i.e. nitrite and nitrate, are reduced in patients with PPHN and increase during ECMO as the PPHN resolves. Eight newborn infants with PPHN on ECMO were studied. Daily urinary concentrations of nitrite/nitrate were measured. We found that mean urinary concentrations of nitrite/nitrate were lower in patients with PPHN than in 47 controls without pulmonary disease (p < 0.005). Urinary nitrite/nitrate concentration showed an initial increase after initiation of ECMO. However, a decrease to concentrations still lower than controls occurred on the day before decannulation. We conclude that intrinsic NO production is significantly lower in patients with PPHN than in controls but increases with oxygenation. We speculate that decreased urinary NO metabolite concentrations imply a role for NO deficiency in the pathogenesis of PPHN.
新生儿持续性肺动脉高压(PPHN)常需体外膜肺氧合(ECMO)治疗,在此期间肺血管阻力会逐渐下降。一氧化氮(NO)是一种最近才被认识的肺血管扩张剂,但其在PPHN中的作用尚不清楚。我们检验了这样一个假设:PPHN患者尿液中NO的代谢产物(即亚硝酸盐和硝酸盐)浓度降低,且随着ECMO治疗期间PPHN病情缓解而升高。我们对8例接受ECMO治疗的PPHN新生儿进行了研究。测量了每日尿液中亚硝酸盐/硝酸盐的浓度。我们发现,PPHN患者尿液中亚硝酸盐/硝酸盐的平均浓度低于47例无肺部疾病的对照组(p < 0.005)。尿液中亚硝酸盐/硝酸盐浓度在开始ECMO治疗后最初有所升高。然而,在拔管前一天又降至仍低于对照组的浓度。我们得出结论,PPHN患者体内内源性NO生成明显低于对照组,但随着氧合作用会增加。我们推测,尿液中NO代谢产物浓度降低意味着NO缺乏在PPHN发病机制中起作用。